Key points are not available for this paper at this time.
Metabolomics identified key disease-related metabolic changes and disease-progression-related changes. Defining metabolic changes during AD disease trajectory and its relationship to clinical phenotypes provides a powerful roadmap for drug and biomarker discovery.
Building similarity graph...
Analyzing shared references across papers
Loading...
Toledo et al. (Tue,) studied this question.
synapsesocial.com/papers/69dd673c80eea7d3f699c834 — DOI: https://doi.org/10.1016/j.jalz.2017.01.020
Jon B. Toledo
Houston Methodist
Matthias Arnold
Ingenieurgesellschaft Auto und Verkehr (Germany)
Gabi Kastenmüller
Queen Mary University of London
Alzheimer s & Dementia
National Institutes of Health
University of Pennsylvania
University of California, San Francisco
Building similarity graph...
Analyzing shared references across papers
Loading...